The Latin America, Middle East and Africa Healthcare Bioconvergence Market would witness market growth of 9.4% CAGR during the forecast period (2022-2028).
The term "healthcare bioconvergence" refers to the fusion of biology with other engineering fields such as Artificial Intelligence (AI), Machine Learning (ML), physics, chemistry, nanotechnology, electronics, computer science, advanced genetic engineering, and material science, all of which are intended to improve human health. The human body is very intricate and composed of many intricate systems.
Following a multidisciplinary and comprehensive strategy makes perfect sense in order to deliver an effective answer to treating the human body, which is precisely what bioconvergence enables innovators to do. Through its ground-breaking advances in therapy, regenerative medicine, diagnostics, and many other fields, Bioconvergence lays the road to attain this holistic route.
When it comes to genuine ideas, breakthroughs, and research, as well as company growth and funding opportunities, the healthcare industry has a lot of untapped potential thanks to this method of developing new goods and services. Drugs are delivered to targeted cancerous tissues using miniature delivery systems, avoiding collateral tissue damage.
The population of the Middle East is aging rapidly, and as age is the primary risk factor for cancer, its incidence and prevalence are rising among all the populations in the area. The national and community-based healthcare services are facing enormous problems as a result of these developments. As per the World Health Organization, one in five UAE adults and adults aged 18 and over are obese. These people, supported by relatively high-income levels, will need higher quality healthcare as the prevalence of lifestyle diseases rises.
The Brazil market dominated the LAMEA Healthcare Bioconvergence Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $3,088.8 million by 2028. The Argentina market is exhibiting a CAGR of 10% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 9.2% during (2022 - 2028).
Based on Application, the market is segmented into Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Healthcare Bioconvergence Market is Predict to reach $169.9 Billion by 2028, at a CAGR of 7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BiomX, Inc., Singota Solutions, Anima Biotech Inc., Ginkgo Bioworks Holdings, Inc., SetPoint Medical Corporation, Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), and BICO Group AB (publ).
Scope of the Study
Market Segments Covered in the Report:
By Application
- Drug Discovery
- Precision Medicine
- Regenerative Medicine
- Diagnostic & Biological Sensors
- Bioelectronics
- Nanorobotics for Drug Delivery
- Engineered Living Materials
- Optogenetics
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- BiomX, Inc.
- Singota Solutions
- Anima Biotech Inc.
- Ginkgo Bioworks Holdings, Inc.
- SetPoint Medical Corporation
- Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
- BICO Group AB (publ)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Healthcare Bioconvergence Market, by Application
1.4.2 LAMEA Healthcare Bioconvergence Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Healthcare Bioconvergence Market by Application
3.1 LAMEA Drug Discovery Market by Country
3.2 LAMEA Precision Medicine Market by Country
3.3 LAMEA Regenerative Medicine Market by Country
3.4 LAMEA Diagnostic & Biological Sensors Market by Country
3.5 LAMEA Bioelectronics Market by Country
3.6 LAMEA Nanorobotics for Drug Delivery Market by Country
3.7 LAMEA Engineered Living Materials Market by Country
3.8 LAMEA Optogenetics Market by Country
Chapter 4. LAMEA Healthcare Bioconvergence Market by Country
4.1 Brazil Healthcare Bioconvergence Market
4.1.1 Brazil Healthcare Bioconvergence Market by Application
4.2 Argentina Healthcare Bioconvergence Market
4.2.1 Argentina Healthcare Bioconvergence Market by Application
4.3 UAE Healthcare Bioconvergence Market
4.3.1 UAE Healthcare Bioconvergence Market by Application
4.4 Saudi Arabia Healthcare Bioconvergence Market
4.4.1 Saudi Arabia Healthcare Bioconvergence Market by Application
4.5 South Africa Healthcare Bioconvergence Market
4.5.1 South Africa Healthcare Bioconvergence Market by Application
4.6 Nigeria Healthcare Bioconvergence Market
4.6.1 Nigeria Healthcare Bioconvergence Market by Application
4.7 Rest of LAMEA Healthcare Bioconvergence Market
4.7.1 Rest of LAMEA Healthcare Bioconvergence Market by Application
Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview
TABLE 1 LAMEA Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 4 LAMEA Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 5 LAMEA Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Precision Medicine Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Precision Medicine Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Regenerative Medicine Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Regenerative Medicine Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Diagnostic & Biological Sensors Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Diagnostic & Biological Sensors Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Bioelectronics Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Bioelectronics Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Nanorobotics for Drug Delivery Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Nanorobotics for Drug Delivery Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Engineered Living Materials Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Engineered Living Materials Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Optogenetics Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Optogenetics Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Healthcare Bioconvergence Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Healthcare Bioconvergence Market by Country, 2022 - 2028, USD Million
TABLE 23 Brazil Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 24 Brazil Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 25 Brazil Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 26 Brazil Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 27 Argentina Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 28 Argentina Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 29 Argentina Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 30 Argentina Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 31 UAE Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 32 UAE Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 33 UAE Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 34 UAE Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 35 Saudi Arabia Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 36 Saudi Arabia Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 37 Saudi Arabia Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 38 Saudi Arabia Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 39 South Africa Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 40 South Africa Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 41 South Africa Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 42 South Africa Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 43 Nigeria Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 44 Nigeria Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 45 Nigeria Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 46 Nigeria Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 47 Rest of LAMEA Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 48 Rest of LAMEA Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 49 Rest of LAMEA Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 50 Rest of LAMEA Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 51 Key Information – BiomX, Inc.
TABLE 52 Key Information – Galvani Bioelectronics, Ltd.
TABLE 53 Key Information – BICO Group AB (publ)
TABLE 54 Key Information – Ginkgo Bioworks Holdings, Inc.
TABLE 55 Key Information – Singota Solutions
TABLE 56 Key Information – Anima Biotech Inc.
TABLE 57 Key Information – Setpoint Medical Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: BICO Group AB (publ)